Suicide PreventionRCTNCT06282263
The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses
A study testing "Awareness Development Program on Suicide Prevention for Oncology Nurses" in people with Suicide Prevention and Nurses, run by Sevda Ozturk at 1 site in Turkey (Türkiye).
Trial summary
The goal of this clinical trial is to investigate the effect of the Awareness Development Programme on Suicide Prevention for Oncology Nurses on the levels of knowledge, stigma and perception of efficacy towards suicide in oncology nurses. The main questions it aims to answer are: 1. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Suicide Prevention, Nurses
- What is being tested?
- "Awareness Development Program on Suicide Prevention for Oncology Nurses"
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 86 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 May 2023to 2 Nov 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- To be willing to participate in the study,
- Being a nurse working in oncology inpatient clinics (medical oncology, medical oncology, gastroenterology oncology, nephrology oncology, urooncology, gynaecological oncology, haematological oncology inpatient clinics), Bone Marrow Transplantation (BMT) unit, outpatient chemotherapy unit and oncology outpatient clinic,
- To know how to use a smart mobile phone or computer.
Who cannot join
- To have training other than undergraduate education for suicide prevention,
- To care for paediatric oncology patients,
- To have worked in a psychiatric clinic or to have postgraduate education in the field of psychiatric nursing.
- Failure to attend two out of three sessions during the training programme,
- Failure to demonstrate the motor skills to participate in online training
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses on the Levels of Suicide Knowledge, Stigma and Perception of Efficacy
The goal of this clinical trial is to investigate the effect of the Awareness Development Programme on Suicide Prevention for Oncology Nurses on the levels of knowledge, stigma and perception of efficacy towards suicide in oncology nurses. The main questions it aims to answer are:
- At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the knowledge levels of nurses about suicide according to the pre-programme and control group?
- At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the perception of efficacy levels of nurses regarding suicide according to the pre-programme and control group.
- At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the stigma levels of nurses towards suicide according to the pre-programme and control group.
- Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test and post-test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.
- Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test-follow-up test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.
Read more
Participants will participate the Awareness Development Programme on Suicide Prevention for Oncology Nurses. Oncology Nurses are expected to complete the pre-test, post-test and follow-up tests.
Researchers will compare control group to see if effect of "the Awareness Development Programme on Suicide Prevention"
Read the detailed description
This research is an intervention study with a pre-test, post-test, follow-up design and control group, which was conducted to examine the effect of the "Awareness Development Program on Suicide Prevention for Oncology Nurses" on oncology nurses' knowledge, stigma and effectiveness perception levels regarding managing suicide risk.
- Conditions
- Suicide Prevention, Nurses
- Being tested
- "Awareness Development Program on Suicide Prevention for Oncology Nurses"
- Keywords
- suicide prevention, oncology
- Medical subject headings
- Suicide Prevention, Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
"Awareness Development Program on Suicide Prevention for Oncology Nurses"Other
While developing the "Awareness Development Programme on Suicide Prevention for Oncology Nurses" applied to the nurses in the experimental group, literature information on suicide risk management and suicide prevention in oncology was included in the study content by the researchers. "Awareness Development Programme on Suicide Prevention for Oncology Nurses" includes 3 sessions and the titles of the programme are as follows:
Session 1: Introduction to Understanding Suicide "Awareness and Development" Session 2: Assessing Suicide Risk Session 3: Management of Suicide Risk "Communication and Referral" The programme was submitted to the opinions of 5 experts before starting the study and the programme was finalised after the feedbacks.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Experimental | "Awareness Development Program on Suicide Prevention for Oncology Nurses" was applied to the nurses in the experimental group. Receives: Other: "Awareness Development Program on Suicide Prevention for Oncology Nurses" |
| Control Group | No intervention | No programme was applied to the control group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
the Literacy of Suicide Scale
A minimum score of 0 and a maximum total score of 27 can be obtained from the scale. The scale does not have any cut-off point. The higher the score obtained from the scale, the higher the level of knowledge about suicide.
Measured: Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.
Efficacy Perception Scale For Suicide Risk Management
This scale consists of 26 items. The lowest score that can be obtained from this scale is 26 and the highest score is 130, and the scale has no cut-off point. An increase in the score obtained from the scale indicates that nurses' self-perception is becoming more positive in relation to their knowledge and skills in the recognition and management of suicide risk.
Measured: Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.
The Stigma of Suicide Scale
There are 55 items in total in the scale. The scale has three subscales: "stigma", "isolation/depression" and "glorification/normalization". Total score is not calculated in the scale. High scores from the "stigma" sub-dimension of the scale indicate high stigma towards suicide. High scores from the "isolation/depression" sub-dimension of the scale indicate that suicide is more associated with depression and isolation, while high scores from the "normalization" sub-dimension indicate that individuals normalize suicide rather than stigmatizing people who commit suicide.
Measured: Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Feb 2024
- Study start25 May 2023
- Primary completion2 Nov 2023
- Study completion2 Nov 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Suicide PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This study was a pre-test, post-test, follow-up design and control group intervention study conducted to examine the effect of "Awareness Development Programme on Suicide Prevention for Oncology Nurses" on oncology nurses' knowledge, stigma and perception of efficacy regarding suicide risk management.
- Masking
- None (open label)
- Enrolment
- 86 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sevda Ozturk
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Sevda Ozturk, Hacettepe University
- Investigators
- Duygu Hiçdurmaz, Prof., Principal investigator, Hacettepe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06282263
- Sponsor's protocol ID
- 1292
- Acronym
- RCT
- Status last verified
- Feb 2024
- First submitted
- 12 Feb 2024
- Last updated
- 28 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses on the Levels of Suicide Knowledge, Stigma and Perception of Efficacy
- ClinicalTrials.gov ID
- NCT06282263
- Acronym / sponsor ID
- RCT / 1292
- Conditions
- Suicide Prevention, Nurses
- Keywords
- suicide prevention, oncology
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 86 participants (actual)
- Lead sponsor
- Sevda OzturkUniversity, hospital or other
- Study start
- 25 May 2023 (actual)
- Primary completion
- 2 Nov 2023 (actual)
- Study completion
- 2 Nov 2023 (actual)
- First posted
- 28 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to investigate the effect of the Awareness Development Programme on Suicide Prevention for Oncology Nurses on the levels of knowledge, stigma and perception of efficacy towards suicide in oncology nurses. The main questions it aims to answer are:
- At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the knowledge levels of nurses about suicide according to the pre-programme and control group?
- At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the perception of efficacy levels of nurses regarding suicide according to the pre-programme and control group.
- At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the stigma levels of nurses towards suicide according to the pre-programme and control group.
- Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test and post-test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.
- Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test-follow-up test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology.
Participants will participate the Awareness Development Programme on Suicide Prevention for Oncology Nurses. Oncology Nurses are expected to complete the pre-test, post-test and follow-up tests.
Researchers will compare control group to see if effect of "the Awareness Development Programme on Suicide Prevention"
Detailed description
This research is an intervention study with a pre-test, post-test, follow-up design and control group, which was conducted to examine the effect of the "Awareness Development Program on Suicide Prevention for Oncology Nurses" on oncology nurses' knowledge, stigma and effectiveness perception levels regarding managing suicide risk.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This study was a pre-test, post-test, follow-up design and control group intervention study conducted to examine the effect of "Awareness Development Programme on Suicide Prevention for Oncology Nurses" on oncology nurses' knowledge, stigma and perception of efficacy regarding suicide risk management.
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Experimental | Other: "Awareness Development Program on Suicide Prevention for Oncology Nurses""Awareness Development Program on Suicide Prevention for Oncology Nurses" was applied to the nurses in the experimental group. |
| Control Group | No intervention | –No programme was applied to the control group. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- To be willing to participate in the study,
- Being a nurse working in oncology inpatient clinics (medical oncology, medical oncology, gastroenterology oncology, nephrology oncology, urooncology, gynaecological oncology, haematological oncology inpatient clinics), Bone Marrow Transplantation (BMT) unit, outpatient chemotherapy unit and oncology outpatient clinic,
- To know how to use a smart mobile phone or computer.
Key exclusion criteria (5 listed)
- To have training other than undergraduate education for suicide prevention,
- To care for paediatric oncology patients,
- To have worked in a psychiatric clinic or to have postgraduate education in the field of psychiatric nursing.
- Failure to attend two out of three sessions during the training programme,
- Failure to demonstrate the motor skills to participate in online training
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| "Awareness Development Program on Suicide Prevention for Oncology Nurses"While developing the "Awareness Development Programme on Suicide Prevention for Oncology Nurses" applied to the nurses in the experimental group, literature information on suicide risk management and suicide prevention in oncology was included in the study content by the researchers. "Awareness Development Programme on Suicide Prevention for Oncology Nurses" includes 3 sessions and the titles of the programme are as follows: Session 1: Introduction to Understanding Suicide "Awareness and Development" Session 2: Assessing Suicide Risk Session 3: Management of Suicide Risk "Communication and Referral" The programme was submitted to the opinions of 5 experts before starting the study and the programme was finalised after the feedbacks. | Other | Intervention Group |
Primary outcome
the Literacy of Suicide Scale
Time frame: Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.
A minimum score of 0 and a maximum total score of 27 can be obtained from the scale. The scale does not have any cut-off point. The higher the score obtained from the scale, the higher the level of knowledge about suicide.
Efficacy Perception Scale For Suicide Risk Management
Time frame: Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.
This scale consists of 26 items. The lowest score that can be obtained from this scale is 26 and the highest score is 130, and the scale has no cut-off point. An increase in the score obtained from the scale indicates that nurses' self-perception is becoming more positive in relation to their knowledge and skills in the recognition and management of suicide risk.
The Stigma of Suicide Scale
Time frame: Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.
There are 55 items in total in the scale. The scale has three subscales: "stigma", "isolation/depression" and "glorification/normalization". Total score is not calculated in the scale. High scores from the "stigma" sub-dimension of the scale indicate high stigma towards suicide. High scores from the "isolation/depression" sub-dimension of the scale indicate that suicide is more associated with depression and isolation, while high scores from the "normalization" sub-dimension indicate that individuals normalize suicide rather than stigmatizing people who commit suicide.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Feb 2024.
- Individual participant dataSharing planned: No
Related trials for Suicide Prevention
Not yet recruitingPhase 1/2
Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling
Suicide, Secure Firearm Storage
Not yet recruitingPhase 2
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Suicidal Ideation, Suicidal Behavior
Recruiting
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Suicidal Ideation
Recruiting
Evaluation of a Multi-Layered Digital Phenotyping, Digital Safety Plan, and Pharmacogenomic Intervention for Suicide Prevention in Adults With Depression
Depressive Disorder, Major Depressive Disorder, Suicidal Ideation
Not yet recruiting
THRIVE: A Recovery-Focused Suicide Prevention Intervention in Crisis Stabilization Centers
Suicide
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Duygu Hiçdurmaz, Prof. principal investigator
Hacettepe University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing "Awareness Development Program on Suicide Prevention for Oncology Nurses" in people with Suicide Prevention and Nurses, run by Sevda Ozturk at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the Literacy of Suicide Scale (time frame: Pretests were applied before the sessions. Intervention sessions of three sessions were implemented 5-8 days apart. Post-tests were administered as soon as the third session was completed. Follow-up tests were conducted 90 days after the post-tests.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.